Clinical Epidemiology, Evaluation, and Management of Dementia in Parkinson Disease

Delaram Safarpour, Allison W. Willis

Research output: Contribution to journalReview article

6 Citations (Scopus)

Abstract

The prevalence of neurodegenerative diseases such as Parkinson disease (PD) will increase substantially, due to the aging of the population and improved treatments leading to better disease-related outcomes. Dementia is the most common nonmotor symptom in PD, and most patients with PD will have cognitive dysfunction and cognitive decline in the course of their disease. The development of cognitive dysfunction in PD greatly limits the ability to participate in activities of daily living and can be a tipping point for nursing home placement or major caregiver stress. Understanding the different causes of dementia and how to reduce the incidence and impact of secondary cognitive dysfunction in PD are necessary skills for primary care physicians and neurologists. In this review, we discuss the clinical epidemiology of dementia in PD with an emphasis on preventable cognitive dysfunction, present tools for outpatient evaluation of cognitive dysfunction, and describe current pharmacological treatments for dementia in PD.

Original languageEnglish (US)
Pages (from-to)585-594
Number of pages10
JournalAmerican Journal of Alzheimer's Disease and other Dementias
Volume31
Issue number7
DOIs
StatePublished - Nov 1 2016
Externally publishedYes

Fingerprint

Parkinson Disease
Dementia
Epidemiology
Aptitude
Primary Care Physicians
Activities of Daily Living
Nursing Homes
Neurodegenerative Diseases
Caregivers
Cognitive Dysfunction
Outpatients
Pharmacology
Incidence
Therapeutics
Population

Keywords

  • dementia
  • epidemiology
  • mild cognitive impairment
  • Parkinson disease
  • Parkinson disease with dementia

ASJC Scopus subject areas

  • Clinical Psychology
  • Geriatrics and Gerontology
  • Psychiatry and Mental health

Cite this

Clinical Epidemiology, Evaluation, and Management of Dementia in Parkinson Disease. / Safarpour, Delaram; Willis, Allison W.

In: American Journal of Alzheimer's Disease and other Dementias, Vol. 31, No. 7, 01.11.2016, p. 585-594.

Research output: Contribution to journalReview article

@article{92e57bc8eac7425ab95f310bb148b41b,
title = "Clinical Epidemiology, Evaluation, and Management of Dementia in Parkinson Disease",
abstract = "The prevalence of neurodegenerative diseases such as Parkinson disease (PD) will increase substantially, due to the aging of the population and improved treatments leading to better disease-related outcomes. Dementia is the most common nonmotor symptom in PD, and most patients with PD will have cognitive dysfunction and cognitive decline in the course of their disease. The development of cognitive dysfunction in PD greatly limits the ability to participate in activities of daily living and can be a tipping point for nursing home placement or major caregiver stress. Understanding the different causes of dementia and how to reduce the incidence and impact of secondary cognitive dysfunction in PD are necessary skills for primary care physicians and neurologists. In this review, we discuss the clinical epidemiology of dementia in PD with an emphasis on preventable cognitive dysfunction, present tools for outpatient evaluation of cognitive dysfunction, and describe current pharmacological treatments for dementia in PD.",
keywords = "dementia, epidemiology, mild cognitive impairment, Parkinson disease, Parkinson disease with dementia",
author = "Delaram Safarpour and Willis, {Allison W.}",
year = "2016",
month = "11",
day = "1",
doi = "10.1177/1533317516653823",
language = "English (US)",
volume = "31",
pages = "585--594",
journal = "American Journal of Alzheimer's Disease and other Dementias",
issn = "1533-3175",
publisher = "SAGE Publications Inc.",
number = "7",

}

TY - JOUR

T1 - Clinical Epidemiology, Evaluation, and Management of Dementia in Parkinson Disease

AU - Safarpour, Delaram

AU - Willis, Allison W.

PY - 2016/11/1

Y1 - 2016/11/1

N2 - The prevalence of neurodegenerative diseases such as Parkinson disease (PD) will increase substantially, due to the aging of the population and improved treatments leading to better disease-related outcomes. Dementia is the most common nonmotor symptom in PD, and most patients with PD will have cognitive dysfunction and cognitive decline in the course of their disease. The development of cognitive dysfunction in PD greatly limits the ability to participate in activities of daily living and can be a tipping point for nursing home placement or major caregiver stress. Understanding the different causes of dementia and how to reduce the incidence and impact of secondary cognitive dysfunction in PD are necessary skills for primary care physicians and neurologists. In this review, we discuss the clinical epidemiology of dementia in PD with an emphasis on preventable cognitive dysfunction, present tools for outpatient evaluation of cognitive dysfunction, and describe current pharmacological treatments for dementia in PD.

AB - The prevalence of neurodegenerative diseases such as Parkinson disease (PD) will increase substantially, due to the aging of the population and improved treatments leading to better disease-related outcomes. Dementia is the most common nonmotor symptom in PD, and most patients with PD will have cognitive dysfunction and cognitive decline in the course of their disease. The development of cognitive dysfunction in PD greatly limits the ability to participate in activities of daily living and can be a tipping point for nursing home placement or major caregiver stress. Understanding the different causes of dementia and how to reduce the incidence and impact of secondary cognitive dysfunction in PD are necessary skills for primary care physicians and neurologists. In this review, we discuss the clinical epidemiology of dementia in PD with an emphasis on preventable cognitive dysfunction, present tools for outpatient evaluation of cognitive dysfunction, and describe current pharmacological treatments for dementia in PD.

KW - dementia

KW - epidemiology

KW - mild cognitive impairment

KW - Parkinson disease

KW - Parkinson disease with dementia

UR - http://www.scopus.com/inward/record.url?scp=84991280559&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84991280559&partnerID=8YFLogxK

U2 - 10.1177/1533317516653823

DO - 10.1177/1533317516653823

M3 - Review article

C2 - 27295974

AN - SCOPUS:84991280559

VL - 31

SP - 585

EP - 594

JO - American Journal of Alzheimer's Disease and other Dementias

JF - American Journal of Alzheimer's Disease and other Dementias

SN - 1533-3175

IS - 7

ER -